Akebia Therapeutics reported $61.7M in Sales Revenues for its first fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Sales Change
Acadia Pharmaceuticals ACAD:US $ 115.47M 15.29M
Akebia Therapeutics AKBA:US $ 61.7M 2.09M
Alnylam Pharmaceuticals ALNY:US $ 213.26M 45.28M
Amgen AMGN:US $ 6238M 608M
Ardelyx ARDX:US $ 0.47M 0.56M
Astellas Pharma 4503:JP Y 303870M 36757M
AstraZeneca AZN:LN 11390M 621M
Bayer BAYN:GR € 14639M 3521M
Biomarin Pharmaceutical BMRN:US $ 519.36M 69.55M
Exelixis EXEL:US $ 355.98M 95.16M
Fresenius Medical Care FME:GR € 4548.37M 98.66M
GlaxoSmithKline GSK:LN 9780M 253M
Intercept Pharmaceuticals ICPT:US $ 88.58M 3.82M
Ironwood Pharmaceuticals IRWD:US $ 97.53M 19.6M
Johnson & Johnson JNJ:US $ 23426M 1378M
Karyopharm Therapeutics KPTI:US $ 47.67M 78.6M
Lexicon Pharmaceuticals LXRX:US $ 0.04M 0.02M
Moderna Inc MRNA:US 6.07B 1.14B
Nektar Therapeutics NKTR:US $ 24.82M 0.19M
Opko Health OPK:US $ 329.22M 72.11M
Prothena PRTA:US 1.15M 19K
Ptc Therapeutics PTCT:US $ 148.74M 16.49M
Regeneron Pharmaceuticals REGN:US $ 2965.1M 1986.6M
Roche Holding ROG:VX 16.44B 474M
Sarepta Therapeutics SRPT:US $ 210.83M 9.37M
Seattle Genetics SGEN:US $ 426.46M 3.39M
Vanda Pharmaceuticals VNDA:US $ 60.19M 7.83M